Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361885228> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W4361885228 abstract "<p>Table S1: Schedule of pharmacokinetic analysis; Table S2: Overview of study dose levels (N=50); Table S3. Adverse events reported at any time during study therapy: grade 3-4 adverse events; Table S4: Veliparib pharmacokinetic (PK) parameters by cohort; Table S5: Total and ultrafilterable platinum pharmacokinetic parameters by cohort; Table S6: Immunohistochemistry results for 28 pre-therapy samples; Figure S1: Veliparib Cmax (ng/mL, panel A) and veliparib AUC0-6 (hr*ng/mL, panel B) by dose Cohort; Figure S2: Veliparib pharmacokinetic parameters (A) Cmax and (B) AUC0-6 at cycles 1 and 4 by cohort; Figure S3: Ultrafilterable platinum pharmacokinetic parameters Cmax and AUC0-24 at cycles 1 and 4 by cohort; Figure S4: Consort 2010 flow diagram for exploratory efficacy analysis comparing germline BRCA mutation positive to wild type; Figure S5: PAR assay results (pg/mL) for 14 patients in dose cohorts 6-8 (120-200 mg)</p>" @default.
- W4361885228 created "2023-04-05" @default.
- W4361885228 creator A5000147752 @default.
- W4361885228 creator A5013172168 @default.
- W4361885228 creator A5016393418 @default.
- W4361885228 creator A5021681826 @default.
- W4361885228 creator A5022401878 @default.
- W4361885228 creator A5024804370 @default.
- W4361885228 creator A5025364402 @default.
- W4361885228 creator A5027371881 @default.
- W4361885228 creator A5028479135 @default.
- W4361885228 creator A5029492518 @default.
- W4361885228 creator A5037198503 @default.
- W4361885228 creator A5042562723 @default.
- W4361885228 creator A5043540755 @default.
- W4361885228 creator A5052437319 @default.
- W4361885228 creator A5058640010 @default.
- W4361885228 creator A5073301255 @default.
- W4361885228 creator A5078939746 @default.
- W4361885228 creator A5084420374 @default.
- W4361885228 creator A5091846363 @default.
- W4361885228 date "2023-03-31" @default.
- W4361885228 modified "2023-09-23" @default.
- W4361885228 title "Supplementary Patients and Methods, Supplementary References, Supplementary Tables 1-6, Supplementary Figures 1-5 from Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or <i>BRCA</i> Mutation–Associated Breast Cancer" @default.
- W4361885228 doi "https://doi.org/10.1158/1078-0432.22458923" @default.
- W4361885228 hasPublicationYear "2023" @default.
- W4361885228 type Work @default.
- W4361885228 citedByCount "0" @default.
- W4361885228 crossrefType "posted-content" @default.
- W4361885228 hasAuthorship W4361885228A5000147752 @default.
- W4361885228 hasAuthorship W4361885228A5013172168 @default.
- W4361885228 hasAuthorship W4361885228A5016393418 @default.
- W4361885228 hasAuthorship W4361885228A5021681826 @default.
- W4361885228 hasAuthorship W4361885228A5022401878 @default.
- W4361885228 hasAuthorship W4361885228A5024804370 @default.
- W4361885228 hasAuthorship W4361885228A5025364402 @default.
- W4361885228 hasAuthorship W4361885228A5027371881 @default.
- W4361885228 hasAuthorship W4361885228A5028479135 @default.
- W4361885228 hasAuthorship W4361885228A5029492518 @default.
- W4361885228 hasAuthorship W4361885228A5037198503 @default.
- W4361885228 hasAuthorship W4361885228A5042562723 @default.
- W4361885228 hasAuthorship W4361885228A5043540755 @default.
- W4361885228 hasAuthorship W4361885228A5052437319 @default.
- W4361885228 hasAuthorship W4361885228A5058640010 @default.
- W4361885228 hasAuthorship W4361885228A5073301255 @default.
- W4361885228 hasAuthorship W4361885228A5078939746 @default.
- W4361885228 hasAuthorship W4361885228A5084420374 @default.
- W4361885228 hasAuthorship W4361885228A5091846363 @default.
- W4361885228 hasBestOaLocation W43618852281 @default.
- W4361885228 hasConcept C104317684 @default.
- W4361885228 hasConcept C112705442 @default.
- W4361885228 hasConcept C126322002 @default.
- W4361885228 hasConcept C143998085 @default.
- W4361885228 hasConcept C182979987 @default.
- W4361885228 hasConcept C185592680 @default.
- W4361885228 hasConcept C22979827 @default.
- W4361885228 hasConcept C2777288759 @default.
- W4361885228 hasConcept C2781312401 @default.
- W4361885228 hasConcept C55493867 @default.
- W4361885228 hasConcept C71924100 @default.
- W4361885228 hasConcept C72563966 @default.
- W4361885228 hasConcept C82381507 @default.
- W4361885228 hasConcept C98274493 @default.
- W4361885228 hasConceptScore W4361885228C104317684 @default.
- W4361885228 hasConceptScore W4361885228C112705442 @default.
- W4361885228 hasConceptScore W4361885228C126322002 @default.
- W4361885228 hasConceptScore W4361885228C143998085 @default.
- W4361885228 hasConceptScore W4361885228C182979987 @default.
- W4361885228 hasConceptScore W4361885228C185592680 @default.
- W4361885228 hasConceptScore W4361885228C22979827 @default.
- W4361885228 hasConceptScore W4361885228C2777288759 @default.
- W4361885228 hasConceptScore W4361885228C2781312401 @default.
- W4361885228 hasConceptScore W4361885228C55493867 @default.
- W4361885228 hasConceptScore W4361885228C71924100 @default.
- W4361885228 hasConceptScore W4361885228C72563966 @default.
- W4361885228 hasConceptScore W4361885228C82381507 @default.
- W4361885228 hasConceptScore W4361885228C98274493 @default.
- W4361885228 hasLocation W43618852281 @default.
- W4361885228 hasLocation W43618852282 @default.
- W4361885228 hasOpenAccess W4361885228 @default.
- W4361885228 hasPrimaryLocation W43618852281 @default.
- W4361885228 hasRelatedWork W2002127959 @default.
- W4361885228 hasRelatedWork W2004706469 @default.
- W4361885228 hasRelatedWork W2080969318 @default.
- W4361885228 hasRelatedWork W2379280247 @default.
- W4361885228 hasRelatedWork W2604417740 @default.
- W4361885228 hasRelatedWork W2899072855 @default.
- W4361885228 hasRelatedWork W2942467058 @default.
- W4361885228 hasRelatedWork W2972898444 @default.
- W4361885228 hasRelatedWork W3151787567 @default.
- W4361885228 hasRelatedWork W3185247380 @default.
- W4361885228 isParatext "false" @default.
- W4361885228 isRetracted "false" @default.
- W4361885228 workType "article" @default.